TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 6.11E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 9.27E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 5.54E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.91E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 190nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 1.25E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 100nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 4.46E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair
TargetEgl nine homolog 1(Homo sapiens (Human))
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Tianjin Institute Of Medical & Pharmaceutical Sciences
Curated by ChEMBL
Affinity DataEC50: 7.97E+3nMAssay Description:Inhibition of PHD2 in human Hep3B cells assessed as increase in EPO production measured after 24 hrs by ELISAMore data for this Ligand-Target Pair